Enhanced Implantable Cellular and Biotherapeutic Agent Delivery System

An advanced implantable device for delivering cellular and biotherapeutic agents, featuring selectively permeable membranes, optimized surface patterns, and real-time permeability control for enhanced therapeutic efficacy.

The original patent disclosed a metallic, nanoporous device for encapsulating cellular and biotherapeutic agents. However, it had limitations in terms of surface area exposure, agent isolation, and real-time control over the diffusion of encapsulated factors. The new inventive concept addresses these limitations by introducing selectively permeable membranes, optimized surface patterns, and real-time permeability control, enabling more efficient and targeted delivery of therapeutic agents.

The enhanced implantable device comprises a metallic, nanoporous structure with a selectively permeable membrane, which is treated with a surface pattern to increase the surface area of exposure to an external environment. The device is configured to wholly isolate metabolically active cellular and biotherapeutic agents, promoting local or systemic diffusion of encapsulated factors. The device may also include a control unit that monitors the diffusion of encapsulated factors and adjusts the device's permeability in real-time to optimize therapeutic efficacy. Additionally, the device can be designed with a bicontinuous morphology, allowing for more efficient agent delivery and improved therapeutic outcomes.

The new inventive concept introduces the use of selectively permeable membranes, optimized surface patterns, and real-time permeability control, which are not present in the original patent. These features enable more efficient and targeted delivery of therapeutic agents, providing a significant improvement over the original invention.

Alternative embodiments of the inventive concept may include the use of different materials for the nanoporous structure, such as polymers or ceramics, or the incorporation of additional features, such as sensors or actuators, to further enhance the device's functionality. Variations of the device may also be designed for specific applications, such as delivering agents to specific tissues or organs.

The enhanced implantable device has significant commercial potential in the field of regenerative medicine, particularly in the treatment of damaged or degenerated tissues. The device's ability to deliver therapeutic agents in a targeted and controlled manner makes it an attractive solution for a range of applications, including tissue engineering, wound healing, and cancer treatment.